Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 USD | +3.85% | +1.89% | -67.40% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 282M 23.5B |
---|---|---|---|---|---|
Net income 2024 * | -129M -10.76B | Net income 2025 * | -164M -13.67B | EV / Sales 2024 * | - |
Net cash position 2024 * | 132M 11.02B | Net cash position 2025 * | 181M 15.12B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.6
x | P/E ratio 2025 * |
-2.61
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | +3.85% | ||
1 week | +1.89% | ||
Current month | -9.80% | ||
1 month | -9.29% | ||
3 months | -67.97% | ||
6 months | -28.19% | ||
Current year | -67.40% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01/15/01 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02/19/02 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04/22/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04/19/04 |
William Rieflin
CHM | Chairman | 64 | 01/15/01 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22/19/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 237 M€ | +2.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 8.1 | +3.85% | 466,173 |
25/24/25 | 7.8 | -1.27% | 855,152 |
24/24/24 | 7.9 | -1.25% | 291,848 |
23/24/23 | 8 | +1.78% | 333,837 |
22/24/22 | 7.86 | -1.13% | 377,331 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.40% | 282M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RAPT Stock